---
$id: https://graph.org.ai/products/commodity/51281616
$type: Product
source: UNSPSC
code: "51281616"
title: "Kanamycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Kanamycin

**UNSPSC Code**: 51281616
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUC37XUP2P. European Medicines Agency schedules Kanamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Kanamycin generally arises in the molecular formula C18H36N4O11. The term KANAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) KANAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule kanamycin under HS 29419000 and SITC 54139. As of Q4 2014, KANAMYCIN remains the US FDA Preferred Term for this commodity. Kanamycin bears US NLM identifiers UMLS ID C0022487 and NCI Concept Code C65997. SMILES: C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.

